Pasello, G., Fabricio, A. S. C., Del Bianco, P., Salizzato, V., Favaretto, A., Piccin, L., . . . Chiarion-Sileni, V. (2024). Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients. Journal of Translational Medicine, 22(1), 1. https://doi.org/10.1186/s12967-024-04920-6
Chicago Style (17th ed.) CitationPasello, Giulia, et al. "Sex-related Differences in Serum Biomarker Levels Predict the Activity and Efficacy of Immune Checkpoint Inhibitors in Advanced Melanoma and Non-small Cell Lung Cancer Patients." Journal of Translational Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12967-024-04920-6.
MLA (9th ed.) CitationPasello, Giulia, et al. "Sex-related Differences in Serum Biomarker Levels Predict the Activity and Efficacy of Immune Checkpoint Inhibitors in Advanced Melanoma and Non-small Cell Lung Cancer Patients." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12967-024-04920-6.